Both SGLT2 and SGLT1 are described to be present in the brain, prostate, and pancreatic cancers; SGLT1 are present on top in ovaries and head and neck cancers; while SGLT2 present on top also in lung cancer. Here, SLC5A1 is linked to lung carcinoma.